FDA Investigator Lindsey Brown, PhD
Lindsey Brown, PhD has conducted inspections on 6 sites in 4 countries as of 31 May 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
31 May 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
India,
Croatia,
United States of America,
Belgium
FDA Investigators that have inspected at least one site in common with Lindsey Brown, PhD:
Ademola O Daramola,
Alanna L Mussawwir Bias,
Amanda L Fyles,
Amy S Graf,
Anthony F Lorenzo,
Arsen Karapetyan,
Art O Czabaniuk,
Azza Talaat,
Bei Y He,
Bijoy Panicker,
Bryan A Galvez,
Burnell M Henry,
Christian D Lynch (CDL),
Christopher R Czajka,
Daniel J Brown,
Davinna Ligons, PhD,
Deborah M Trout,
Diane L Raccasi,
Dorothy W Lee,
Dr. Barbara D Paul, PhD,
Dr. Jun Liu, PhD,
Dr. Ralph M Bernstein, PhD,
Eileen A Liu,
Emilie E Kahn,
Emily J Orban,
Emine Guvenmaiorov,
Frances Namuswe, PhD,
Gene D Arcy,
Helen B Ricalde,
Howard Anderson, PhD,
Ian L Mcwilliams,
Jacob G Lutz,
Jacqueline Mdiaz Albertini,
James C Maclaughlin,
James R Evans,
James W Whitney,
Jeffrey D Meng,
Jessica Hankins, PhD,
Joel D Martinez,
Joohi Castelvetere,
Joseph A Piechocki,
Joseph T Madak,
Kristen Nickens, PhD,
Lakshmi Narasimhan, PhD,
Larry K Austin,
Laura Fontan, MS,
Laureen F Kononen,
Lauren M Lilly, PhD,
Laurie Nelson,
Laurimer Kuilan Torres,
Linda F Murphy,
Lisa B Orr,
Malini Wileman, PhD,
Maria Gutierrez Lugo, PhD,
Marion Michaelis,
Maxwell Van Tassell, PhD,
Merry Christie, PhD,
Miah I Schneider,
Michael L Chasey,
Michael Shanks, MS,
Michele L Forster, PhD,
Mihaly S Ligmond,
Muralidhara B Gavini, PhD,
Omotunde O Osunsanmi,
Parul M Patel,
Patsy J Domingo,
Paul A Bonneau,
Paula A Trost,
Prabhu P Raju,
Rebecca E Dombrowski,
Regina T Brown,
Reyes Candau Chacon, PhD,
Rose Ashley,
S Lori Brown, PhD MPH,
Salwa K Poole,
Sandra A Hughes,
Sanket N Patel,
Sarah E Rhoades,
Sarah Kennett, PhD,
Sarah M Meng,
Sarah M Napier,
Scott T Ballard,
Shafiq S Ahadi,
Shirshendu K Deb, PhD,
Sidney B Priesmeyer,
Susan M Jackson,
Susanne M Richardson, MS RAC,
Thuy T Nguyen, LCDR,
Tina M Pawlowski,
Tina S Roecklein,
Viviana Matta,
Wayne E Seifert,
Yasamin Ameri,
Yi Wang, PhD,
Yiwei Li,
Youmin Wang,
Yun Wu, PhD,
Zhong Li, PhD
Lindsey Brown, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| July, 2021 | FDA 483 | ENDO USA, Inc. - Form 483, 2021-07-20 |
| October, 2021 | FDA 483 Response | Catalent Belgium SA - Form 483R, 2021-11-17 |
| June, 2023 | FDA 483 | FUJIFILM Diosynth Biotechnologies Texas, LLC - Form 483, 2023-06-07 |
| October, 2021 | EIR | Catalent Belgium SA - EIR, 2021-10-26 |
| May, 2019 | FDA 483 | Tanvex BioPharma USA, Inc - Form 483, 2019-05-02 |
| October, 2021 | FDA 483 | Catalent Belgium SA - Form 483, 2021-10-26 |
| April, 2017 | FDA 483 | Biocon Biologics Limited - Form 483, 2017-04-07 |
| November, 2019 | FDA 483 | Hospira Zagreb d.o.o. - Form 483, 2019-11-22 |
| March, 2024 | FDA 483 | Novo Nordisk A/S - Form 483, 2024-03-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more